PRKAA2 and type 2 diabetes mellitus: NLRP3 inflammasome components and the activation of caspase-1 and IL-1β were significantly upregulated in monocyte-derived macrophages from T2D patients and were reduced following treatment with metformin, an insulin sensitizing drug that activates AMPK.